ARISTOTLE: A phase III trial comparing concurrent capecitabine with capecitabine and irinotecan (Ir) chemoradiation as preoperative treatment for MRI-defined locally advanced rectal cancer (LARC).

David Sebag-Montefiore, Richard Adams, Simon Bach

Research output: Contribution to journal › Article › peer-review

Original languageEnglish
Pages (from-to)4101-410
Number of pages9
JournalJournal of Clinical Oncology
Publication statusPublished - 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  • SDG 3 - Good Health and Well-being

Cite this